Key Points
- Tredegar director Carl Tack III sold 5,435 shares on May 18 at an average price of $7.81, totaling about $42,447. After the sale, he still held 73,421 shares, reducing his stake by 6.89%.
- Tredegar recently reported quarterly EPS of $0.15 on revenue of $186.49 million, with a net margin of 3.89% and return on equity of 12.91%.
- Analysts currently view the stock cautiously: Weiss Ratings upgraded Tredegar from “sell” to “hold,” and MarketBeat data shows an overall average rating of “Hold.”
Tredegar Corporation (NYSE:TG - Get Free Report) Director Carl Tack III sold 5,435 shares of the company's stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $7.81, for a total transaction of $42,447.35. Following the sale, the director directly owned 73,421 shares in the company, valued at $573,418.01. This trade represents a 6.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Tredegar Price Performance
NYSE TG opened at $7.65 on Thursday. The company's 50 day simple moving average is $8.48 and its two-hundred day simple moving average is $8.23. Tredegar Corporation has a 1 year low of $6.25 and a 1 year high of $10.53. The stock has a market capitalization of $267.90 million, a PE ratio of 9.11 and a beta of 0.82.
Tredegar (NYSE:TG - Get Free Report) last released its quarterly earnings results on Friday, May 8th. The basic materials company reported $0.15 EPS for the quarter. The firm had revenue of $186.49 million during the quarter. Tredegar had a net margin of 3.89% and a return on equity of 12.91%.
Analysts Set New Price Targets
Separately, Weiss Ratings raised Tredegar from a "sell (d-)" rating to a "hold (c-)" rating in a report on Monday, May 11th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Tredegar currently has an average rating of "Hold".
Check Out Our Latest Research Report on Tredegar
Hedge Funds Weigh In On Tredegar
A number of hedge funds and other institutional investors have recently bought and sold shares of TG. AQR Capital Management LLC increased its holdings in shares of Tredegar by 31.4% in the 1st quarter. AQR Capital Management LLC now owns 17,158 shares of the basic materials company's stock worth $132,000 after buying an additional 4,097 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of Tredegar during the 1st quarter worth $144,000. Geode Capital Management LLC grew its position in Tredegar by 0.3% in the second quarter. Geode Capital Management LLC now owns 589,275 shares of the basic materials company's stock worth $5,187,000 after acquiring an additional 1,506 shares in the last quarter. Rhumbline Advisers grew its position in Tredegar by 4.8% in the second quarter. Rhumbline Advisers now owns 44,096 shares of the basic materials company's stock worth $388,000 after acquiring an additional 2,021 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its stake in Tredegar by 225.3% in the second quarter. Tower Research Capital LLC TRC now owns 6,889 shares of the basic materials company's stock valued at $61,000 after acquiring an additional 4,771 shares during the last quarter. Hedge funds and other institutional investors own 79.24% of the company's stock.
Tredegar Company Profile
(
Get Free Report)
Tredegar Corporation is a diversified manufacturer specializing in high-performance plastic films and aluminum extrusions. Headquartered in Richmond, Virginia, the company operates through two primary segments—Films and Manufactured Products—serving a broad range of industries that include flexible packaging, medical devices, electronics, building and construction. Tredegar's operations focus on delivering tailored solutions that meet demanding specifications for barrier properties, film strength and extrusion tolerances.
The Films segment produces a variety of polyolefin films, including cast and blown polyethylene, BOPP (biaxially oriented polypropylene), barrier films and specialty medical-grade films.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
